Filing excerpt
Caris Assure for therapy selection is available in all U.S. states (other than New York, where we intend to apply for approval from New York State’s Clinical Laboratory Evaluation Program (“NY CLEP”)) and in Puerto Rico.
The company's blood-based solution, Caris Assure, is currently unavailable in the key New York market, creating a revenue gap and a specific regulatory hurdle. They are actively preparing an application for the New York State’s Clinical Laboratory Evaluation Program (NY CLEP), likely requiring specialized consulting and documentation services to enter the market.
Filing excerpt
Caris Assure for therapy selection is available in all U.S. states (other than New York, where we intend to apply for approval from New York State’s Clinical Laboratory Evaluation Program (“NY CLEP”)) and in Puerto Rico.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kcomplianceBurdenGet every 10-K signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/353a8dec-ab00-4c15-9fd7-514b354cda58 returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "353a8dec-ab00-4c15-9fd7-514b354cda58",
"signal_type": "sec-10k",
"signal_subtype": "complianceBurden",
"detected_at": "2026-03-10T06:44:07.681+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "The company's blood-based solution, Caris Assure, is currently unavailable in the key New York market, creating a revenue gap and a specific regulatory hurdle. They are actively preparing an application for the New York State’s Clinical Laboratory Evaluation Program (NY CLEP), likely requiring specialized consulting and documentation services to enter the market.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Caris seeking NY CLEP approval to offer Caris Assure solution in New York.",
"excerpts": "Caris Assure for therapy selection is available in all U.S. states (other than New York, where we intend to apply for approval from New York State’s Clinical Laboratory Evaluation Program (“NY CLEP”)) and in Puerto Rico.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000016/cai-20251231.htm",
"filing_date": "2026-03-03",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"New York",
"United States",
"Puerto Rico"
]
}
}
curl https://signals.autobound.ai/v1/signals/353a8dec-ab00-4c15-9fd7-514b354cda58 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.